162 related articles for article (PubMed ID: 2525529)
1. Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
Kempf P; Pompetzki H; Oppermann A; Wittenberger R; Siebert J; Fell JJ; Dieterich HA
Infection; 1989; 17(3):177-81. PubMed ID: 2525529
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and safety of teicoplanin.
Stille W; Sietzen W; Dieterich HA; Fell JJ
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():69-79. PubMed ID: 2965134
[TBL] [Abstract][Full Text] [Related]
3. A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
Lewis P; Garaud JJ; Parenti F
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():61-7. PubMed ID: 2965133
[TBL] [Abstract][Full Text] [Related]
4. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases].
Dureux JB; Canton P; Chavanet P; Chippaux C; Dupeyron JP; Estavoyer JM; Giorgi C; Jaeger A; Jehl F; Kazmierzack A
Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564
[TBL] [Abstract][Full Text] [Related]
5. Teicoplanin in the treatment of skin and soft tissue infections: results of a multicentre study.
Lang E; Földes M; Marghescu S
Infection; 1991; 19(3):190-4. PubMed ID: 1832418
[TBL] [Abstract][Full Text] [Related]
6. Teicoplanin in the treatment of infection caused by gram-positive organisms.
Williams AH; Grüneberg RN; Webster A; Ridgway GL
J Hosp Infect; 1986 Mar; 7 Suppl A():101-3. PubMed ID: 2871091
[TBL] [Abstract][Full Text] [Related]
7. Teicoplanin--a new agent for gram-positive bacterial infections.
Eggleston M; Ofosu J
Infect Control Hosp Epidemiol; 1988 May; 9(5):209-11. PubMed ID: 2967322
[No Abstract] [Full Text] [Related]
8. Teicoplanin, a new antibiotic effective against gram-positive bacterial infections of the skin and soft tissues.
Bochud-Gabellon I; Regamey C
Dermatologica; 1988; 176(1):29-38. PubMed ID: 2962889
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
Pauluzzi S; Del Favero A; Menichetti F; Baratta E; Moretti VM; Di Filippo P; Pasticci MB; Guerciolini R; Patoia L; Frongillo RF
J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bone and soft tissue infections with teicoplanin.
Marone P; Concia E; Andreoni M; Suter F; Cruciani M
J Antimicrob Chemother; 1990 Mar; 25(3):435-9. PubMed ID: 2140111
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria.
de Lalla F; Santoro D; Rinaldi E; Suter F; Cruciani M; Guaglianone MH; Rizzardini G; Pellegata G
J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109
[TBL] [Abstract][Full Text] [Related]
12. Teicoplanin in the treatment of skin and soft tissue infections.
Turpin PJ; Taylor GP; Logan MN; Wood MJ
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis.
Neville LO; Baillod RA; Brumfitt W; Hamilton-Miller JM
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():123-31. PubMed ID: 2965124
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy and safety of teicoplanin in gram-positive infections: a multicentre study.
Lang E; Schäfer V; Schaaf B; Dennhardt R
Scand J Infect Dis Suppl; 1990; 72():54-60. PubMed ID: 2151067
[TBL] [Abstract][Full Text] [Related]
15. Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.
Galanakis N; Giamarellou H; Vlachogiannis N; Dendrinos C; Daikos GK
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):130-4. PubMed ID: 2968907
[TBL] [Abstract][Full Text] [Related]
16. An open study of teicoplanin in the treatment of gram-positive infections.
Nathwani D; Reid TM; Gould IM; Golder D; Smith CC; Douglas JG
J Chemother; 1991 Oct; 3(5):315-20. PubMed ID: 1839742
[TBL] [Abstract][Full Text] [Related]
17. Infections due to gram-positive organisms in children: possible role for teicoplanin.
Dagan R; Einhorn M; Howard CB; Williams AH
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():37-41. PubMed ID: 1829075
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Campoli-Richards DM; Brogden RN; Faulds D
Drugs; 1990 Sep; 40(3):449-86. PubMed ID: 2146108
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
Van der Auwera P; Aoun M; Meunier F
Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
Glupczynski Y; Lagast H; Van der Auwera P; Thys JP; Crokaert F; Yourassowsky E; Meunier-Carpentier F; Klastersky J; Kains JP; Serruys-Schoutens E
Antimicrob Agents Chemother; 1986 Jan; 29(1):52-7. PubMed ID: 2942100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]